Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic Review.

Liu W, Xiong X, Yang X, Chu F, Liu H.

Evid Based Complement Alternat Med. 2016;2016:8565907. Review.

2.

A propensity matched comparison of return to work and quality of life after stenting or coronary artery bypass surgery.

Maznyczka AM, Howard JP, Banning AS, Gershlick AH.

Open Heart. 2016 Jan 13;3(1):e000322. doi: 10.1136/openhrt-2015-000322.

3.

Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study.

Zarifis J, Grammatikou V, Kallistratos M, Katsivas A; Investigators of the Prospective, Noninterventional, Observational Study of the Antianginal Efficacy of Ivabradine During a 4-Month Treatment of a Greek Population With Coronary Artery Disease..

Clin Cardiol. 2015 Dec;38(12):725-32. doi: 10.1002/clc.22479.

4.

Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.

Magnuson EA, Farkouh ME, Fuster V, Wang K, Vilain K, Li H, Appelwick J, Muratov V, Sleeper LA, Boineau R, Abdallah M, Cohen DJ; FREEDOM Trial Investigators..

Circulation. 2013 Feb 19;127(7):820-31. doi: 10.1161/CIRCULATIONAHA.112.147488.

5.

Health-Related Quality of Life among Patients with Coronary Artery Disease: A Post-Treatment Follow-Up Study in Iran.

Tofighi S, Ahmad Kiadaliri A, Sadeghifar J, Raadabadi M, Mamikhani J.

Cardiol Res Pract. 2012;2012:973974. doi: 10.1155/2012/973974.

6.

Does age or bilateral disease influence the value of hip arthroplasty?

Lawless BM, Greene M, Slover J, Kwon YM, Malchau H.

Clin Orthop Relat Res. 2012 Apr;470(4):1073-8. doi: 10.1007/s11999-011-2118-1.

7.

Effect of race on the clinical outcomes in the bypass angioplasty revascularization investigation trial.

Melsop K, Brooks MM, Boothroyd DB, Hlatky MA.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):186-90. doi: 10.1161/CIRCOUTCOMES.108.802942.

8.

Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

Hlatky MA, Boothroyd DB, Melsop KA, Kennedy L, Rihal C, Rogers WJ, Venkitachalam L, Brooks MM; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group..

Circulation. 2009 Dec 22;120(25):2550-8. doi: 10.1161/CIRCULATIONAHA.109.912709.

9.

The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers.

Huang ES, Zhang Q, Brown SE, Drum ML, Meltzer DO, Chin MH.

Health Serv Res. 2007 Dec;42(6 Pt 1):2174-93; discussion 2294-323.

10.

Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.

Griffin SC, Barber JA, Manca A, Sculpher MJ, Thompson SG, Buxton MJ, Hemingway H.

BMJ. 2007 Mar 24;334(7594):624.

11.

Outcomes of coronary artery bypass graft surgery.

Hawkes AL, Nowak M, Bidstrup B, Speare R.

Vasc Health Risk Manag. 2006;2(4):477-84. Review.

Items per page

Supplemental Content

Support Center